Nitric Oxide Interacts with Caveolin-1 to Facilitate Autophagy-Lysosome-Mediated Claudin-5 Degradation in Oxygen-Glucose Deprivation-Treated Endothelial Cells

Mol Neurobiol. 2016 Nov;53(9):5935-5947. doi: 10.1007/s12035-015-9504-8. Epub 2015 Oct 29.

Abstract

Using in vitro oxygen-glucose deprivation (OGD) model, we have previously demonstrated that 2-h OGD induces rapid, caveolin-1-mediated dissociation of claudin-5 from the cellular cytoskeletal framework and quick endothelial barrier disruption. In this study, we further investigated the fate of translocated claudin-5 and the mechanisms by which OGD promotes caveolin-1 translocation. Exposure of bEND3 cells to 4-h OGD, but not 2-h OGD plus 2-h reoxygenation, resulted in claudin-5 degradation. Inhibition of autophagy or the fusion of autophagosome with lysosome, but not proteasome, blocked OGD-induced claudin-5 degradation. Moreover, knockdown of caveolin-1 with siRNA blocked OGD-induced claudin-5 degradation. Western blot analysis showed a transient colocalization of caveolin-1, claudin-5, and LC3B in autolysosome or lipid raft fractions at 2-h OGD. Of note, inhibiting autophagosome and lysosome fusion sustained the colocalization of caveolin-1, claudin-5, and LC3B throughout the 4-h OGD exposure. EPR spin trapping showed increased nitric oxide (NO) generation in 2-h OGD-treated cells, and inhibiting NO with its scavenger C-PTIO or inducible nitric oxide synthase (iNOS) inhibitor 1400W prevented OGD-induced caveolin-1 translocation and claudin-5 degradation. Taken together, our data provide a novel mechanism underlying endothelial barrier disruption under prolonged ischemic conditions, in which NO promotes caveolin-1-mediated delivery of claudin-5 to the autophagosome for autophagy-lysosome-dependent degradation.

Keywords: Autophagy; Caveolin-1; Claudin-5; Lysosome; Oxygen-glucose deprivation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Autophagy* / drug effects
  • Benzoates / pharmacology
  • Caveolin 1 / metabolism*
  • Claudin-5 / metabolism*
  • Endothelial Cells / cytology
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Glucose / deficiency*
  • Imidazoles / pharmacology
  • Imines / pharmacology
  • Lysosomes / drug effects
  • Lysosomes / metabolism*
  • Mice
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase Type II / metabolism
  • Oxygen
  • Protein Transport / drug effects
  • Proteolysis* / drug effects

Substances

  • Benzoates
  • Caveolin 1
  • Claudin-5
  • Imidazoles
  • Imines
  • N-((3-(aminomethyl)phenyl)methyl)ethanimidamide
  • 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole
  • Nitric Oxide
  • Nitric Oxide Synthase Type II
  • Glucose
  • Oxygen